Advanced Therapies
Animal-origin-free proteins for cell, gene, and regenerative therapy manufacturing.
From cell expansion and differentiation to viral vector production, cryopreservation, and final formulation, InVitria’s animal-origin-free recombinant proteins support the development and manufacturing of advanced therapies. Explore solutions designed to support cell growth, process consistency, and therapeutic stability.
Explore Applications Across Cell, Gene & Regenerative Therapies
Each routes to a workflow page showing exactly where InVitria proteins fit.
CAR-T
Animal-origin-free albumin, transferrin, IL-2, and insulin-transferrin supplements from leukapheresis through cryopreservation for CAR-T manufacturing.
ExploreTCR-T
Animal-origin-free albumin, transferrin, IL-2, and insulin-transferrin supplements from leukapheresis through cryopreservation for TCR-T manufacturing.
ExploreTReg
Animal-origin-free albumin, IL-2, transferrin, and insulin-transferrin supplements from leukapheresis through cryopreservation for regulatory T cell therapy.
ExploreTIL
Animal-origin-free albumin, IL-2, transferrin, and insulin-transferrin supplements from tumor tissue procurement through cryopreservation for TIL therapy.
ExploreNK
Animal-origin-free albumin, transferrin, IL-2, and insulin-transferrin supplements from starting material through cryopreservation for NK cell therapy.
ExploreDendritic Cell
Animal-origin-free albumin, transferrin, and insulin-transferrin supplements from leukapheresis through cryopreservation for dendritic cell therapy.
ExploreiPSC
Animal-origin-free albumin, transferrin, LIF, and insulin-transferrin supplements from somatic cell collection through cryopreservation for iPSC manufacturing.
ExploreMSC
Animal-origin-free albumin, transferrin, and insulin-transferrin supplements from tissue procurement through cryopreservation for MSC manufacturing.
ExploreLentiviral Vector (LVV)
Animal-origin-free albumin, transferrin, and insulin-transferrin supplements from producer cell expansion through storage for lentiviral vector production.
ExploreAdeno Associated Virus (AAV)
Animal-origin-free albumin, transferrin, and insulin-transferrin supplements from producer cell expansion through storage for AAV production.
ExploreRetroviral
Animal-origin-free albumin, transferrin, and insulin-transferrin supplements from packaging cell expansion through storage for retroviral vector production.
ExploreWound Healing
Animal-origin-free albumin, transferrin, lactoferrin, and insulin-transferrin supplements from source tissue through storage for cell-based wound healing.
ExploreBioprint & Organoid
Animal-origin-free albumin, transferrin, lactoferrin, and insulin-transferrin supplements from cell sourcing through storage for bioprinting and organoids.
ExploreTissue Engineering
Animal-origin-free albumin, transferrin, lactoferrin, and insulin-transferrin supplements from cell preparation through storage for tissue engineering.
ExploreExtracellular Vesicles
Animal-origin-free albumin, transferrin, and insulin-transferrin supplements from cell sourcing through final fill for extracellular vesicle therapy.
ExploreDefined Recombinant Reagents for Advanced Therapy Development & Manufacturing
Cell, gene, and regenerative therapy manufacturing requires consistent, high-quality raw materials to support cell growth, differentiation, expansion, and product stability.
Traditional serum-containing and animal-derived supplements can introduce variability and additional raw material qualification requirements. Animal-origin-free recombinant proteins offer defined alternatives for developing more controlled manufacturing processes.
InVitria’s portfolio of recombinant albumin, transferrin, cytokines, and cell culture supplements provides solutions for evaluation across upstream cell culture, downstream processing, and final formulation, supporting the development of scalable advanced therapy manufacturing workflows.
Talk to the ProApps team
Discuss your advanced therapy program.
The step, the cell type, the format, the working concentration, the scale, and the regulatory file the material has to support.